711 filings
Page 24 of 36
8-K
i63yfm
8 Nov 18
KemPharm, Inc. Reports Third Quarter 2018 Results
4:12pm
D
4v7g30o o0x8i
2 Nov 18
$1.15M in options / securities to be acquired, sold $1.15M, 1 investor
5:07pm
8-K
kcm3w
30 Oct 18
Entry into a Material Definitive Agreement
4:07pm
4
eew6sjg2 r00so27t56g
15 Oct 18
KEMPHARM / Timothy J. Sangiovanni ownership change
4:28pm
4
v6wzxx 2ge9
12 Oct 18
KEMPHARM / Travis C Mickle ownership change
4:35pm
4
gbfgipdlbf7
12 Oct 18
KEMPHARM / Gordon K Johnson ownership change
4:12pm
4
ae5xy r5c
11 Oct 18
KEMPHARM / R. LaDuane Clifton ownership change
6:52pm
4
y5pf qgi1zkr
9 Oct 18
KEMPHARM / Managers, L.L.C. DSC ownership change
4:01pm
424B5
igkers ra2pje72g
5 Oct 18
Prospectus supplement for primary offering
5:07pm
8-K
u92d0myh 6a3fp8um
5 Oct 18
KemPharm Announces Pricing of Public Offering of Common Stock
10:03am
8-K
kre qnimqq4
4 Oct 18
KemPharm Announces Proposed Public Offering of Common Stock
5:27pm
424B5
nu9 fvdsbgl
4 Oct 18
Prospectus supplement for primary offering
5:26pm
8-K
5xkcisp87 b7hygl
17 Sep 18
Regulation FD Disclosure
12:00am
424B5
va3a bda9ot1h0w2q5vq
4 Sep 18
Prospectus supplement for primary offering
12:00am
8-K
42g2x6jaxjhbbdf8co9j
4 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
iy0u r3s5a87f
31 Aug 18
Departure of Directors or Certain Officers
12:00am
8-K
9vvwu de6w196
9 Aug 18
KemPharm, Inc. Reports Second Quarter 2018 Results
4:06pm
8-K
iui0 tkn3
9 Aug 18
Regulation FD Disclosure
8:42am